Haemonetics (HAE) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall St set to open higher as tech rebounds, Micron earnings eyed
- Brent hits lowest since before start of Iran war on expectations of smoother oil flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Stay long AI-capex winners into the peak, Stifel says despite bubble fears
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Haemonetics Reports 1st Quarter Fiscal 2016 Revenue of $213 Million and Adjusted EPS of $0.35, Reaffirms Full Fiscal Year Guidance
July 27, 2015 6:00 AM EDTBRAINTREE, Mass., July 27, 2015 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) today reported first quarter fiscal 2016 revenue of $213.4 million, down 5%. Revenue declined 2% in constant currency in the quarter.Â
The Company reported a GAAP net loss of $0.3 million and a GAAP net loss per share of $0.01 in the quarter. Exclusive of transformation, restructuring and deal amortization expenses detailed below, adjusted net income was $18.0 million and adjusted earnings per share were $0.35, both down 9%.1  Â
1Q FISCAL 2016 STRATEGIC AND PRODUCT GROWTH HIGHLIGHTS
Strong constant... More